Smooth Switch to the EAEU Marketing Authorization for Medicinal Products

Webinar: Smooth Switch to the EAEU Marketing Authorization for Medicinal Products

The webinar will highlight the practical tips and guide you through the crucial steps of marketing authorization upgrade to the Eurasian Economic Union (EAEU) one, ultimately leading you towards a successful submission strategy development.

As of now, all national medicinal product marketing authorizations are valid in EAEU until their expiry date. However, the mentioned marketing authorizations must be revalidated according to the EAEU regulations until December 31st, 2025.

You will learn:

What do you need to prepare and implement now to timely and successfully transition to the EAEU marketing authorization?

  1. What are the main points you need to consider when going into the upgrade procedure?
  2. What do you need to know about EAEU GMP certification?
  3. What are the readability user testing requirements?
  4. Timelines

Preparing for a marketing authorization upgrade?

Create a successful submission strategy development. Explore your options in an informal chat.

Who Should Attend?

Professionals from the following fields:

  • Regulatory Managers
  • Regulatory Strategy Managers
  • RA Partnerships Operations Manager
  • QA Managers supporting RA
  • RA Healthcare Compliance Managers

Duration: 45 min.

Speaker: Regulatory Affairs Project Manager CIS, Nargiz Asgarova, who will share her expertise regarding drug registration in the Eurasian Economic Union.

Nargiz Asgarova

Nargiz Asgarova

Regulatory Affairs Project Manager CIS

Other content that might interest you:

Let’s celebrate success

Let’s celebrate success

Recently, we had the chance to reflect on our last 10 years of operations and were astonished by the unprecedented growth facts: The Clinical Research department grew 8 times the size it was back in 2013. Regulatory Affairs services became available to 32 new...

read more
How can a CRO support Mergers & Acquisition

How can a CRO support Mergers & Acquisition

The role of Contract Research Organizations (CROs) in supporting mergers and acquisitions (M&As) is not a new concept, as CROs have been providing services in this area for several years. However, the demand for these services may have increased in recent years...

read more
The Role of Regulatory Intelligence in Pharmacovigilance

The Role of Regulatory Intelligence in Pharmacovigilance

Regulatory Intelligence is a reliable and invaluable tool when it comes to pharmacovigilance. It's so important because it allows companies to remain up-to-date with the most recent drug safety data and identify new information quickly. What Is Regulatory...

read more

Big Enough To Cover  All Your Needs. Small Enough To Care.

Discover the tailored solutions that Biomapas provides to accelerate your clinical trials and optimize your drug development process.

Clinical Research

Regulatory Affairs

Pharmacovigilance

Medical Information